1 / 8

Epo Biomarkers Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

Epo Biomarkers Market Report- 2026 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.

SANJAYCMI
Download Presentation

Epo Biomarkers Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EPO BIOMARKERS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Epo Biomarkers Market - Overview Epo Erythropoietin Alfa, Erythropoietin Beta, Erythropoietin Zeta, Erythropoietin Theta, and Darbepoietin Alfa), by Application (End-stage Renal Disorder, Cancer, Rheumatoid Arthritis, AIDS, Myelodysplastic Syndrome, Neurology, Hematology, and Others), by End User (Diagnostic Centers, Hospitals, and Ambulatory Care and Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027 Biomarkers Market, by Biomarker Type (Recombinant Human Erythropoietin, Erythropoietin (Epo) is a glycoprotein hormone that consists 165 amino acids with four complex carbohydrate chains attached to the peptide at four linkage sites. Epo adjusts red blood cell production to meet the tissue oxygen demand. Epo biomarkers are used for treating cancers and associated anemia, AIDS, and mostly in end-stage renal disorders (ESRD). There are five different type of epo biomarkers. Commercially used epo for humans is known as recombinant human erythropoietin (rHuEPO). Increasing research and development in epo biomarker technology and high prevalence of ESRD is expected to boost growth of the global epo biomarker market. For instance, in 2015, Molecular Health — a cloud-based healthcare decision support technology that aids in evidence-based treatment decisions and improved outcomes — confirmed the discovery that ephrin-type B receptor 4 (EPHB4) is an alternative epo receptor. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing-insight/epo- biomarkers-market-4057 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Global Epo Biomarkers Market: Drivers The epo biomarkers market is expected to witness significant growth over the forecast period, owing to increasing launch and adoption of erythropoietin alfa in cancer patients who are suffering from anemia. For instance, in November 2018, Pfizer launched epoetin alfa biosimilar — Retacrit — at 33% discounted rate than the original drug in the U.S. for treatment of anemia caused by chronic kidney disease and chemotherapy. Furthermore, increasing prevalence of ESRD, which causes kidney failure and is often fatal is expected to boost the market growth. According to the U.S. Renal Data System Annual Data Report of 2016, over 660,000 people in the U.S. were treated for kidney failure or ESRD. Out of these, 468,000 were dialysis patients and over 193,000 had a functioning kidney transplant. Global Epo Biomarkers Market: Restraints A major restraining factor for the epo biomarkers market growth is the over-production of red blood cells due to over-expression of epo biomarkers, which leads to absolute polycythemia and other conditions. Overproduction of epo may be an adaptive response associated with conditions that produce tissue hypoxia such as living at high altitude, chronic obstructive pulmonary disease, cyanotic heart disease, and sleep apnea. According to an article published in Biospace Journal in 2015, in the U.S. between 40% and 90% of cancer patients suffer from chemotherapy-induced anemia. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/4057 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Global Epo Biomarkers Market: Regional Analysis North America is expected to hold a dominant position in the epo biomarkers market over the forecast period, owing to robust healthcare infrastructure and increasing prevalence of cancer in the region. Asia Pacific is expected to witness significant growth in the epo biomarkers market, owing to presence of major companies such as 3Sbio Group, Biocon Ltd., Genscript, Intas Pharmaceuticals Ltd., Kyowa Hakko Kirin Co., Ltd., and Shandong Kexing Bioproducts Co. Ltd. Moreover, increasing prevalence of AIDS in India, China, Pakistan, and Bangladesh is also contributing to epo biomarker market growth. For instance, according to the UNAIDS Data 2018 for Asia Pacific region, in India 2.1 million people are living with HIV AIDS at the end of 2017. Global Epo Biomarkers Market: Competitive Landscape Key players operating in the global epo biomarkers market include, Technologies, Inc., Amgen Inc., Bioagilytix Labs, Biocon Ltd., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Galenica Ag, Genscript, Glaxosmithkline Plc., Intas Pharmaceuticals Ltd., Johnson & Johnson, Inc., Kyowa Hakko Kirin Co., Ltd., Teva Pharmaceutical Industries Ltd., Merck Kgaa, Myriad Rbm, Novartis Ag, Pacific Biomarkers, Pfizer Inc., Shandong Kexing Bioproducts Co. Ltd., Siemens Ag, and Thermo Fisher Scientific. 3Sbio Group, Agilent Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4057 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related